CN104304293A - Method for preventing and treating anthracnose of orchid - Google Patents
Method for preventing and treating anthracnose of orchid Download PDFInfo
- Publication number
- CN104304293A CN104304293A CN201410556073.9A CN201410556073A CN104304293A CN 104304293 A CN104304293 A CN 104304293A CN 201410556073 A CN201410556073 A CN 201410556073A CN 104304293 A CN104304293 A CN 104304293A
- Authority
- CN
- China
- Prior art keywords
- orchid
- anthracnose
- preventing
- thiophanate methyl
- carbendazim
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a method for preventing and treating anthracnose of orchid. The method is characterized in that a chemical with an active component consisting of thiophanate methyl and carbendazim is applied to orchid, wherein the mass ratio of thiophanate methyl to carbendazim is (3-1) to 1. Compared with the conventional method, the method has the advantages that the control effect on the anthracnose of the orchid is obviously better.
Description
technical field
The present invention relates to a kind of method of preventing and treating cymbidium anthracnose.
Background technology
Cymbidium anthracnose is one of Major Diseases of orchid cultivation, and occurrence scope is quite extensive at home, all can occur throughout the year, especially spring, autumn to fall ill heavier.If disease can not get effective control, final blade is withered gradually from top to bottom, scattered syringe needle shape pore on later stage scab, i.e. the Spreading source that infects again of germ, and reduces ornamental value.
Summary of the invention
The object of this invention is to provide a kind of method of preventing and treating cymbidium anthracnose.
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
Prevent and treat a method for cymbidium anthracnose, use to orchid the medicine that active component is made up of thiophanate methyl and carbendazim, wherein, the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
Described medicine contains pharmaceutic adjuvant.Insecticide-applying way can adopt conventional spray pattern.By drug dilution 500-1000 doubly to being applied to orchid.
Embodiment
Below in conjunction with preferred embodiment, the present invention will be described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
Embodiment 1
By 70% commercially available thiophanate methyl wetting powder with 50% carbendazol wettable powder in mass ratio for 1:1 mixes, 900 times of water diluents of this medicament are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 95%(of 30 days 330 after medication).
Contrast 1: by 70% thiophanate methyl wetting powder dilute with water 800 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 4 times, the total number of sheets of the control efficiency 79%(of 30 days 247 after medication).
Contrast 2: after 50% carbendazol wettable powder dilute with water 500 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 25%(of 30 days 150 after medication).
Embodiment 2
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 2:1 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 96%(of 30 days 300 after medication) every 7 days.
Embodiment 3
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 4:5 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 93%(of 30 days 280 after medication) every 7 days.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (1)
1. prevent and treat a method for cymbidium anthracnose, use to orchid the medicine that active component is made up of thiophanate methyl and carbendazim, wherein, the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410556073.9A CN104304293A (en) | 2014-10-20 | 2014-10-20 | Method for preventing and treating anthracnose of orchid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410556073.9A CN104304293A (en) | 2014-10-20 | 2014-10-20 | Method for preventing and treating anthracnose of orchid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104304293A true CN104304293A (en) | 2015-01-28 |
Family
ID=52359731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410556073.9A Pending CN104304293A (en) | 2014-10-20 | 2014-10-20 | Method for preventing and treating anthracnose of orchid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104304293A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107646456A (en) * | 2017-11-01 | 2018-02-02 | 柳州市绿盈庄花卉有限公司 | A kind of breeding method for controlling orchid spot |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164582A (en) * | 1976-04-13 | 1979-08-14 | Kemira Oy | Synergistic fungicidal compositions |
CN1353933A (en) * | 2001-09-28 | 2002-06-19 | 唐永琦 | Medicine for silkworm and its preparation method |
CN101411280A (en) * | 2008-12-12 | 2009-04-22 | 唐山师范学院 | Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area |
CN103787785A (en) * | 2014-03-06 | 2014-05-14 | 郭志红 | Crop bactericide additive |
-
2014
- 2014-10-20 CN CN201410556073.9A patent/CN104304293A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164582A (en) * | 1976-04-13 | 1979-08-14 | Kemira Oy | Synergistic fungicidal compositions |
CN1353933A (en) * | 2001-09-28 | 2002-06-19 | 唐永琦 | Medicine for silkworm and its preparation method |
CN101411280A (en) * | 2008-12-12 | 2009-04-22 | 唐山师范学院 | Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area |
CN103787785A (en) * | 2014-03-06 | 2014-05-14 | 郭志红 | Crop bactericide additive |
Non-Patent Citations (3)
Title |
---|
易绮斐 等: "兰花主要病害及其防治", 《植物保护》, vol. 30, no. 1, 8 February 2004 (2004-02-08) * |
桂炳中: "多菌灵、苯菌灵和甲基托布津的科学使用", 《科学种养》, 1 February 2008 (2008-02-01), pages 7 - 2 * |
赵书梅: "蝴蝶兰炭疽病的发生与防治", 《河北农业科技》, 2 October 2004 (2004-10-02), pages 19 - 1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107646456A (en) * | 2017-11-01 | 2018-02-02 | 柳州市绿盈庄花卉有限公司 | A kind of breeding method for controlling orchid spot |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000609A (en) | Methods of treatment with cyp3a4 substrate drugs. | |
MX2021000148A (en) | Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer. | |
WO2021050953A8 (en) | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | |
MY201105A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
MX2015008396A (en) | 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same. | |
EA201992862A1 (en) | Nasal Drug Forms of Dihydroergotamine | |
HRP20211824T1 (en) | Modulators of complement activity | |
CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
WO2015187998A3 (en) | Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy | |
MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
WO2015058664A8 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
EP4279128A3 (en) | Novel antibody binding to tfpi and composition comprising the same | |
EA033446B1 (en) | Heterocyclic compound for treating macular degeneration and/or stargardt's disease | |
WO2016142708A3 (en) | Pharmaceutical composition | |
WO2016040169A3 (en) | Mucolytic agents for use in tretaing pulmonary sarcoidosis | |
UY37306A (en) | COMBINATIONS OF ACTIVE COMPOUNDS | |
EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
MX2021009219A (en) | Triamterene or nolatrexed for use in the treatment of phenylketonuria. | |
CN104304293A (en) | Method for preventing and treating anthracnose of orchid | |
WO2017030383A3 (en) | Pharmaceutical composition for preventing or treating muscular dystrophy including bakuchiol as active ingredient | |
MY197518A (en) | Preventive and/or therapeutic agent of immune disease | |
CN104351232A (en) | Composition for preventing and curing orchid anthracnose | |
MX2020005310A (en) | Combination product comprising dicycloplatin and preparation method and use thereof. | |
CN104351221A (en) | Composition for preventing and treating orchid southern blight |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |
|
RJ01 | Rejection of invention patent application after publication |